Medicare Enrolled

Dr. Noe Olvera, MD

Rheumatology · Victoria, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
2705 HOSPITAL DR, Victoria, TX 77901
3615741893
In practice since 2007 (19 years)
NPI: 1417006784 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Olvera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olvera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Olvera

Dr. Noe Olvera is a rheumatology in Victoria, TX, with 19 years in practice. Based on federal Medicare data, Dr. Olvera performed 145,080 Medicare services across 1,033 unique beneficiaries.

Between the years covered by Open Payments, Dr. Olvera received a total of $12,685 from 32 pharmaceutical and/or device companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Olvera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 10% volume in TX$ $12,685 industry payments

Medicare Practice Summary

Medicare Utilization ↗
145,080
Medicare services
Top 10% in TX for rheumatology
1,033
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,636 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)63,200$4$15
Tocilizumab injection (Actemra)41,280$5$10
Abatacept infusion (Orencia)22,750$33$75
Golimumab infusion (Simponi Aria)15,450$11$50
Office visit, established patient (20-29 min)636$59$135
Administration of chemotherapy into vein, 1 hour or less511$95$600
Steroid injection (triamcinolone)388$1$4
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle317$53$160
Office visit, established patient (30-39 min)297$84$150
New patient office visit (45-59 min)83$108$350
New patient office visit (30-44 min)62$80$225
Aspiration and/or injection of fluid large joint using ultrasound guidance60$67$200
Drug injection, under skin or into muscle26$9$210
Joint injection, major joint20$48$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.3% high complexity
72.9% medium
0.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,685
Total received (2018-2024)
Avg $1,812/year across 7 years
Top 26% in TX for rheumatology
32
Companies
245
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,279 (57.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,618 (28.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,788 (14.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$982
2023
$371
2022
$129
2021
$27
2020
$454
2019
$978
2018
$9,745

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ironwood Pharmaceuticals, Inc
$7,279
PFIZER INC.
$1,553
Amgen Inc.
$677
Janssen Biotech, Inc.
$373
E.R. Squibb & Sons, L.L.C.
$367
GENZYME CORPORATION
$306
Lilly USA, LLC
$267
UCB, Inc.
$219
Novartis Pharmaceuticals Corporation
$196
Celgene Corporation
$192
SANOFI-AVENTIS U.S. LLC
$178
AstraZeneca Pharmaceuticals LP
$136
Fresenius Kabi USA, LLC
$117
Hikma Pharmaceuticals USA
$113
AbbVie, Inc.
$100
ABBVIE INC.
$98
Genentech USA, Inc.
$83
Medtronic USA, Inc.
$69
ANI Pharmaceuticals, Inc.
$57
SOBI, INC
$51
Radius Health, Inc.
$42
Horizon Pharma plc
$41
Octapharma USA, Inc.
$24
Aurinia Pharma U.S., Inc.
$20
FIDIA PHARMA USA INC.
$18
Alexion Pharmaceuticals, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Bioventus LLC
$16
Antares Pharma, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
Mallinckrodt Hospital Products Inc.
$14
Horizon Therapeutics plc
$14
Top 3 companies account for 75.0% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Bimzelx · COSENTYX · Cimzia · DUEXIS · DUZALLO · EUCRISA · EVENITY · Enbrel · GELSYN 3 · Humira · Hymovis · IDACIO · INTELLIS · KEVZARA · KINERET · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $9 per 100 Medicare services performed
Looking for a rheumatology in Victoria?
Compare rheumatologys in the Victoria area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
2
Per 100K population
2.2
County median income
$70,101
Nearest hospital
CITIZENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Olvera is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and consulting-driven industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Olvera experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Olvera performed 63,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Olvera receive payments from pharmaceutical companies?
Yes. Dr. Olvera received a total of $12,685 from 32 companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Olvera's costs compare to other rheumatologys in Victoria?
Dr. Olvera's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Olvera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →